vatalanib has been researched along with Choroid Neovascularization in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aono, H; Ban, M; Honda, T; Inaba, T; Inoue, K; Kawashima, K; Okamoto, K; Sasabuchi, Y; Tajima, H; Takeno, Y; Yamamoto, M | 1 |
| Campochiaro, PA; Kwak, N; Okamoto, N; Wood, JM | 1 |
2 other study(ies) available for vatalanib and Choroid Neovascularization
| Article | Year |
|---|---|
Pyridylmethylthio derivatives as VEGF inhibitors. Part 1.
Topics: Anilides; Animals; Arthritis, Experimental; Cell Line; Choroidal Neovascularization; Disease Models, Animal; Endothelial Cells; Humans; Mice; Neoplasms; Pyridines; Rats; Structure-Activity Relationship; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2010 |
VEGF is major stimulator in model of choroidal neovascularization.
Topics: Animals; Choroidal Neovascularization; Endothelial Growth Factors; Enzyme Inhibitors; Genistein; Lymphokines; Male; Mice; Mice, Inbred C57BL; Phosphorylation; Phthalazines; Platelet-Derived Growth Factor; Protein Kinase C; Pyridines; Pyrimidines; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |